Headache Archives

Truvada approved to reduce HIV infection risk in uninfected

FDA approves first drug for reducing the risk of sexually acquired HIV infection — Evidence-based approach enhances existing prevention strategies – The U.S. Food and Drug Administration has approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners.

Belviq lorcaserin approved to treat overweight or obese adults

FDA approves Belviq to treat some overweight or obese adults – Belviq (lorcaserin hydrochloride) is approved as an addition to a reduced-calorie diet and exercise, for chronic weight management. This obesity drug is approved by US FDA for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).

High blood pressure risk rising in US kids

More hospitalizations, higher charges, for kids with high blood pressure – Hospitalizations for children with high blood pressure and related charges dramatically increased during 10 years ending in 2006, according to a study published in the American Heart Association journal Hypertension. This nationally-based study is the first in which researchers examined hypertension hospitalizations in children.

Chronic migraine and daily headaches patients get little benefit from botox injections

Botox injections associated with only modest benefit for chronic migraine and daily headaches – Although botulinum toxin A (“Botox”) injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for patients with chronic migraine headaches and chronic daily headaches, although botox injections were not associated with greater benefit than placebo for preventing episodic migraine or chronic tension-type headaches.

Migraine linked to increased risk of depression in women

Migraines linked to depression in women — Risk of depression appears to stay elevated even if the pain stops, research finds – Women who have migraine or have had them in the past are at an increased risk for developing depression compared to women who have never had migraine. This new study is linking depression in women to migraine in women.

Migraine in mom may increase baby’s risk of colic

Moms with migraines twice as likely to have baby with colic — Study shows moms who suffer migraines more likely to have colicky babies – Mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant.

Prevnar 13 vaccine approved for people ages 50 and older

FDA expands use of Prevnar 13 vaccine for people ages 50 and older – Prevnar 13, a pneumonia vaccine, is approved for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.

Pfizer new drug could provide a new treatment option for postmenopausal women

Pfizer new drug BZA/CE could provide a new treatment option for symptomatic postmenopausal women with a uterus – Pfizer Inc. will announce new one-year results from the Selective estrogens, Menopause, And Response to Therapy [SMART]-5 Phase 3 study of the safety and efficacy of the investigational tissue selective estrogen complex (TSEC) bazedoxifene/conjugated estrogens (BZA/CE) at the 22nd annual meeting of the North American Menopause Society (NAMS), September_21-24 in Washington, D.C.

Remicade infliximab approved to treat ulcerative colitis in children

FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

Scorpion stings treatment Anascorp approved in US

FDA approves the first specific treatment for scorpion stings – The U.S. Food and Drug Administration approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

Substantial recovery in headache with placebo treatment

Substantial recovery rate with placebo effect in headache treatment — New study in the Journal of Manipulative and Physiological Therapeutics – Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb most daily activities.

High dose aspirin reduces pain for severe headache and migraine

High-dose aspirin reduces pain for severe headache and migraine – An inexpensive, hundred-year-old therapy for pain ? aspirin ? is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center.